Search

everythinglearnresearchcommunity

for

Search:↓

Tissue engineering could be a future solution for hair loss, but it's currently expensive, complex, and hard to apply in real-world treatments.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Botulinum toxin injections can help treat common hair loss in men, but more research is needed to confirm this and understand how it works.

Nanocarriers with plant extracts show promise for safe and effective hair growth treatment.

Hair follicle cells help protect against immune attacks by regulating T-cell activity.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Finasteride caused a rare skin rash in a man, which improved after stopping the medication.

Alopecia areata involves specific T-cells, unlike androgenetic alopecia.

Ifidancitinib, a JAK inhibitor, effectively regrows hair in mice with alopecia by tiring out harmful T cells.

Platelet-rich plasma may help restore immune balance in bald patches, but its effectiveness in treating hair loss is limited.

Hair loss may link to weaker COVID-19 immunity, suggesting possible need for extra vaccine boost.

Hair follicles may help teach the immune system to tolerate new self-antigens, but this can sometimes cause hair loss.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Expanded CD8+ T cells are linked to Alopecia Areata and may cause relapse after treatment.

Higher PD-1 levels are linked to fewer immune cells in hair follicles in alopecia areata.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

T-cell patterns in skin help distinguish alopecia areata from androgenetic alopecia.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Defective T cell metabolism can cause early skin aging and poor hair follicle stem cell function.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.